Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hepatitis A symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of appetite, dark urine, muscle pain and yellowing of the skin and eyes (jaundice). Its treatment includes antiemetics and pain relievers.
The Hepatitis A pipeline drugs market research report provides an analysis of the Hepatitis A drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects.
Hepatitis A Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Hepatitis A pipeline drugs market are intramuscular, and oral. The intramuscular route of drug administration is most preferred for Hepatitis A medication.
Hepatitis A Pipeline Drugs Market Analysis, by Routes of Administration
To know more about RoA in the Hepatitis A pipeline drugs market, download a free report sample
Hepatitis A Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the Hepatitis A pipeline drugs market are Inactivated Vaccine, Live Attenuated Vaccine, Vaccine, and Small Molecule.
Hepatitis A Pipeline Drugs Market Analysis, by Molecule Types
For more insights on molecule types, download a free report sample
Competitive Landscape
Some of the leading companies in the Hepatitis A pipeline drugs market are Biological E Ltd, Boryung Pharmaceutical Co Ltd, China National Pharmaceutical Group Corp, Etna Biotech Srl, F. Hoffmann-La Roche Ltd, Indian Immunologicals Ltd, Liaoning Cheng Da Biotechnology Co Ltd, Novo Medi Sciences Pvt Ltd, Sinovac Biotech Ltd, SK Bioscience Ltd, and Zydus Lifesciences Ltd among others.
Hepatitis A Pipeline Drugs Market Analysis, by Leading Companies
To know more about the leading companies in the Hepatitis A pipeline drugs market, download a free report sample
Hepatitis A Pipeline Drugs Market Report Overview
Key Routes of Administration | Intramuscular, and Oral |
Key Molecule Types | Inactivated Vaccine, Live Attenuated Vaccine, Vaccine, and Small Molecule |
Key Companies | Biological E Ltd, Boryung Pharmaceutical Co Ltd, China National Pharmaceutical Group Corp, Etna Biotech Srl, F. Hoffmann-La Roche Ltd, Indian Immunologicals Ltd, Liaoning Cheng Da Biotechnology Co Ltd, Novo Medi Sciences Pvt Ltd, Sinovac Biotech Ltd, SK Bioscience Ltd, and Zydus Lifesciences Ltd |
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Hepatitis A (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Hepatitis A (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Hepatitis A (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Hepatitis A (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Hepatitis A (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Hepatitis A (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Hepatitis A (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Boryung Pharmaceutical Co Ltd
China National Pharmaceutical Group Corp
Etna Biotech Srl
F. Hoffmann-La Roche Ltd
Indian Immunologicals Ltd
Liaoning Cheng Da Biotechnology Co Ltd
Novo Medi Sciences Pvt Ltd
Sinovac Biotech Ltd
SK Bioscience Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the routes of administration in the Hepatitis A pipeline drugs market?
The routes of administration in the Hepatitis A pipeline drugs market are intramuscular, and oral.
-
What are the molecule types in the Hepatitis A pipeline drugs market?
The molecule types in the Hepatitis A pipeline drugs market are Inactivated Vaccine, Live Attenuated Vaccine, Vaccine, and Small Molecule.
-
Which are the leading companies in the Hepatitis A pipeline drugs market?
Some of the leading companies in the Hepatitis A pipeline drugs market are Biological E Ltd, Boryung Pharmaceutical Co Ltd, China National Pharmaceutical Group Corp, Etna Biotech Srl, F. Hoffmann-La Roche Ltd, Indian Immunologicals Ltd, Liaoning Cheng Da Biotechnology Co Ltd, Novo Medi Sciences Pvt Ltd, Sinovac Biotech Ltd, SK Bioscience Ltd, and Zydus Lifesciences Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.